PEOPLE - BTG (UK) makes appointment:
This article was originally published in Clinica
Executive Summary
Healthcare industry regulatory and investment consultant William Jenkins has been named as a non-executive director on the board of the London, UK technology transfer company BTG. Dr Jenkins had senior regulatory and clinical research responsibilities at Ciba/Novartis and Glaxo and also has UK Department of Health experience.